Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$181.79
+1.0%
$178.71
$141.74
$263.24
$13.18B1.64914,976 shs1.28 million shs
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$73.79
-0.3%
$75.05
$58.93
$95.25
$43.31B1.125.24 million shs7.03 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$509.36
0.0%
$528.03
$413.82
$616.00
$182.56B1.671.68 million shs2.83 million shs
Stryker Corporation stock logo
SYK
Stryker
$375.44
+0.6%
$374.95
$314.93
$406.19
$143.35B0.911.33 million shs2.01 million shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
0.00%+2.22%+5.32%+7.82%-24.94%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.00%-1.77%-1.35%+4.73%-16.64%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.00%-0.55%-6.14%+3.43%+17.09%
Stryker Corporation stock logo
SYK
Stryker
0.00%-0.42%-0.76%+1.09%+7.68%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Align Technology, Inc. stock logo
ALGN
Align Technology
4.6814 of 5 stars
4.33.00.03.83.31.71.3
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
4.5008 of 5 stars
2.25.00.04.02.52.52.5
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
4.7836 of 5 stars
3.45.00.04.03.02.51.9
Stryker Corporation stock logo
SYK
Stryker
4.9094 of 5 stars
3.45.03.34.23.02.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Align Technology, Inc. stock logo
ALGN
Align Technology
2.67
Moderate Buy$241.2532.71% Upside
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
2.40
Hold$80.208.69% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.70
Moderate Buy$588.9515.63% Upside
Stryker Corporation stock logo
SYK
Stryker
2.79
Moderate Buy$427.3013.81% Upside

Current Analyst Ratings Breakdown

Latest ISRG, EW, ALGN, and SYK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/9/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Sell$515.00 ➝ $440.00
6/5/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy
6/2/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Dbs Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/22/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$84.00 ➝ $95.00
5/22/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$590.00 ➝ $650.00
5/22/2025
Stryker Corporation stock logo
SYK
Stryker
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$443.00 ➝ $455.00
5/13/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$80.00 ➝ $83.00
5/5/2025
Stryker Corporation stock logo
SYK
Stryker
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$450.00
5/5/2025
Stryker Corporation stock logo
SYK
Stryker
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$390.00 ➝ $400.00
5/5/2025
Stryker Corporation stock logo
SYK
Stryker
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
5/2/2025
Stryker Corporation stock logo
SYK
Stryker
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$405.00 ➝ $456.00
(Data available from 6/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Align Technology, Inc. stock logo
ALGN
Align Technology
$4.00B3.30$8.99 per share20.23$51.60 per share3.52
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$5.44B7.96$2.73 per share27.04$17.06 per share4.33
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$8.35B21.86$7.99 per share63.76$46.41 per share10.98
Stryker Corporation stock logo
SYK
Stryker
$22.60B6.34$15.08 per share24.90$54.13 per share6.94
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Align Technology, Inc. stock logo
ALGN
Align Technology
$421.36M$5.4933.1120.311.9310.29%13.52%8.36%7/23/2025 (Estimated)
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$4.17B$7.0010.5426.833.7275.48%16.62%12.64%7/23/2025 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.32B$6.8274.6966.765.4028.41%14.43%12.81%7/17/2025 (Estimated)
Stryker Corporation stock logo
SYK
Stryker
$2.99B$7.4050.7325.322.8312.31%23.74%11.25%7/29/2025 (Estimated)

Latest ISRG, EW, ALGN, and SYK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/17/2025Q2 2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.92N/AN/AN/A$2.35 billionN/A
5/1/2025Q1 2025
Stryker Corporation stock logo
SYK
Stryker
$2.73$2.84+$0.11$1.69$5.68 billion$5.87 billion
4/30/2025Q1 2025
Align Technology, Inc. stock logo
ALGN
Align Technology
$2.00$2.13+$0.13$1.27$977.90 million$979.26 million
4/23/2025Q1 2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$0.60$0.64+$0.04$0.61$1.40 billion$1.41 billion
4/22/2025Q1 2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.71$1.81+$0.10$1.92$2.19 billion$2.25 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Align Technology, Inc. stock logo
ALGN
Align Technology
N/AN/AN/AN/AN/A
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
Stryker Corporation stock logo
SYK
Stryker
$3.360.89%N/A45.41%32 Years

Latest ISRG, EW, ALGN, and SYK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/8/2025
Stryker Corporation stock logo
SYK
Stryker
quarterly$0.840.88%6/30/20256/30/20257/31/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Align Technology, Inc. stock logo
ALGN
Align Technology
N/A
1.21
1.08
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.06
4.45
3.66
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.98
3.97
Stryker Corporation stock logo
SYK
Stryker
0.69
1.64
1.00

Institutional Ownership

CompanyInstitutional Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
88.43%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
79.46%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%
Stryker Corporation stock logo
SYK
Stryker
77.09%

Insider Ownership

CompanyInsider Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
0.66%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.34%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.70%
Stryker Corporation stock logo
SYK
Stryker
5.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Align Technology, Inc. stock logo
ALGN
Align Technology
20,94572.49 million72.01 millionOptionable
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
15,800586.60 million584.61 millionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
15,638358.42 million355.91 millionOptionable
Stryker Corporation stock logo
SYK
Stryker
53,000381.69 million361.84 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Align Technology stock logo

Align Technology NASDAQ:ALGN

$181.79 +1.78 (+0.99%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$181.26 -0.53 (-0.29%)
As of 06/20/2025 06:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

Edwards Lifesciences stock logo

Edwards Lifesciences NYSE:EW

$73.79 -0.19 (-0.26%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$73.82 +0.04 (+0.05%)
As of 06/20/2025 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$509.36 -0.13 (-0.03%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$511.78 +2.43 (+0.48%)
As of 06/20/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Stryker stock logo

Stryker NYSE:SYK

$375.44 +2.18 (+0.58%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$375.84 +0.41 (+0.11%)
As of 06/20/2025 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.